PwC and D&B provided both financial, tax, environmental, HR, legal and GDPR due diligence services and financial, tax and legal assistance for the negotiation of the acquisition documents.
“The transaction proves investors’ interest in successful businesses built by Romanian entrepreneurs. It has been a fast and intense process in which we assisted the buyer through all stages of the transaction”, said Cornelia Bumbăcea, Deals Partner, PwC Romania.
The PwC Deals team involved in the transaction was coordinated by Cornelia Bumbacea, Partner, and included Andreea Bistriceanu, Director, Iulia Basaraba, Senior Associate and Irina Sarlau, Senior Associate.
The PwC Tax team consisted of Andreea Mitirita, Partner, Alexandra Popa, Senior Manager, Irina Nutescu, Senior Manager, Izabela Stoicescu, Senior Manager, Andreea Giovani, Senior Manager and Gabriela Batîr, Senior Manager.
The D&B David si Baias team involved in the transaction comprised Anda Rojanschi, Partner D&B David si Baias, Adina Oprea, Senior Coordinating Lawyer, Lucian Bozian, Senior Coordinating Lawyer, Daniel Vinerean, Senior Coordinating Lawyer, Mihaela Papandreia, Senior Lawyer, Sonia Voinescu, Senior Lawyer, and Adriana Popa, Collaborative Lawyer.
Established in 2017 by Mario Debel and Alychlo, CERES Pharma is a company active in developing and distributing medical drugs, medical devices, biocides and cosmetics, with a focus on natural products. In the coming years, the company’s growth strategy will focus on expanding its product portfolio by developing qualitative dietary supplements and pharmaceutical preparations in the Benelux and Central and Eastern Europe.
The transaction will be looked into by Romania’s antitrust watchdog and D&B lawyers will assist the buyer with this procedure as well.